Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial - Chan, F K; Wong, V W; Suen, B Y (Lancet, 2007)
et al.